Skip to main content
Displaying 62 of 2916 articles.
...This finding was particularly surprising because, until then, specific defects in cell intrinsic immunity had only been linked to a predisposition to some viral infections, from Covid to herpes to encephalitis. It had never been shown to play a role in bacterial disease. "This is the fi...

...COVID-19 among infectious diseases.  Now, a new study in Nature Microbiology maps the methods by which Mycobacterium tuberculosis (Mtb) bacteria shrug off antibiotics, revealing hundreds of drug targets that could strip this pathogen of its notorious resis...

...Immunity in people who fought off COVID last year and later received mRNA vaccines is impressively broad,” says Paul Bieniasz, head of the Laboratory of Retrovirology at Rockefeller. “This tells us that although natural infection or the vaccines lead to immunity, they have in no way com...

...Now, a study identifies a protein that blocks infection by SARS-CoV-2, the coronavirus that causes COVID-19, along with several other types. The protein, known as LY6E, stops the virus from fusing with host cells. Researchers in the lab of Rockefeller’s Charles M. Rice, along with colla...

...In fact, some existing antivirals, as well as several new candidates under investigation specifically for COVID-19 act on RdRp—including remdesivir, which is currently being used in several countries for treatment of severe cases. These antiviral drugs try to lodge into nooks and cranni...

COVID-19 dominated scientific research this past year, with good reason. When the worst pandemic of the century struck, scientists from all disciplines banded together to fend off a virus that will have claimed at least 1.6 million lives by the new year. But basic science did not come to a...

...The findings play into the larger body of Casanova’s work, which continues to demonstrate that the severity of  influenza, tuberculosis, COVID-19, and other diseases, is not solely dependent on the pathogen itself, but on genetics of the host, too.

...Rice, is developing so-called monoclonal antibody treatments in which a potent antibody is identified and mass-produced to be used as medication for COVID-19. To better understand if such interventions will remain effective over time, they examined viral mutation patterns using a stand-...

...Increasingly, scientists have shown that genetics play a central role in determining whether the pathogens that cause a wide range of disease—including influenza, warts, and COVID-19—end up causing serious diseases. The lab of Jean-Laurent Casanova, which has spent 25 years studying the...

What if mathematicians could have seen COVID-19 coming, or could predict the next outbreak? Is it possible that numbers, manipulated by statistics, might warn of future market fluctuations and environmental disasters, or herald vast shifts in finance, trade, and employment? It’s hard to pr...